Evidence map›Paper›PMID 21772967›Full record

ArticleStroke research and treatment2011

Intracranial atherosclerotic disease.

Maria Khan, Imama Naqvi, Asha Bansari, Ayeesha Kamran Kamal

Open access · goldAbstract read
In one paragraph

Article in Stroke research and treatment, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. High resolution 7T MR imaging in characterizing culprit intracranial atherosclerotic plaques.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Current state of acute stroke care in Southeast Asian countries.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Study protocol: asymptomatic intracranial atherosclerotic disease in pakistanis.Journal of vascular and interventional neurology · 2015
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. An Investigation to Identify Potential Risk Factors Associated with Common Chronic Diseases Among the Older Population in India.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria KhanFellow International Cerebrovascular Translational Clinical Research Training Program, Stroke Service, Aga Khan University Hospital, Karachi 74800, Pakistan.
Imama Naqvi
Asha Bansari
Ayeesha Kamran Kamal
Aga Khan University Hospital · PK

Funding

International Cerebrovascular Translational Clinical Research Training ProgramD43TW008660 · FIC · AGA KHAN UNIVERSITY (PAKISTAN) · PI KAMAL, AYEESHA KAMRAN, SHAFQAT, SAAD · 2010 to 2014
$502k
FIC NIH HHS D43 TW008660
6 · The paper itself

Abstract

Intracranial atherosclerotic disease (ICAD) is the most common proximate mechanism of ischemic stroke worldwide. Approximately half of those affected are Asians. For diagnosis of ICAD, intra-arterial angiography is the gold standard to identify extent of stenosis. However, noninvasive techniques including transcranial ultrasound and MRA are now emerging as reliable modalities to exclude moderate to severe (50%-99%) stenosis. Little is known about measures for primary prevention of the disease. In terms of secondary prevention of stroke due to intracranial atherosclerotic stenosis, aspirin continues to be the preferred antiplatelet agent although clopidogrel along with aspirin has shown promise in the acute phase. Among Asians, cilostazol has shown a favorable effect on symptomatic stenosis and is of benefit in terms of fewer bleeds. Moreover, aggressive risk factor management alone and in combination with dual antiplatelets been shown to be most effective in this group of patients. Interventional trials on intracranial atherosclerotic stenosis have so far only been carried out among Caucasians and have not yielded consistent results. Since the Asian population is known to be preferentially effected, focused trials need to be performed to establish treatment modalities that are most effective in this population.

Identifiers

PMID21772967
PMCPMC3137956
OpenAlexW2021410694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.